|
|
Introduction |
| The do’s and don’ts when using AIIRAs in daily practice in hypertension: an introduction |
S1 |
| PS Sever
|
|
Full Article (PDF)
|
|
Original Articles |
| The role of angiotensin II receptor antagonists in hypertension management: focus on candesartan cilexetil |
S3 |
| G Mancia & G Grassi
|
|
Abstract
Full Article (PDF)
|
|
| Benefits and pitfalls of cardiovascular risk assessment |
S11 |
| NR Poulter
|
|
Abstract
Full Article (PDF)
|
|
| Applying evidence-based medicine to current practice: a round table panel discussion |
S17 |
| GT McInnes,
G Mancia,
PS Sever & NR Poulter
|
|
Abstract
Full Article (PDF)
|
|
| Blocking the tissue renin-angiotensin system: the future cornerstone of therapy |
S23 |
| T Unger,
M Azizi & GG Belz
|
|
Abstract
Full Article (PDF)
|
|
| Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data |
S33 |
| JM Mallion & JP Baguet
|
|
Abstract
Full Article (PDF)
|
|
